<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00474734</url>
  </required_header>
  <id_info>
    <org_study_id>07-063</org_study_id>
    <nct_id>NCT00474734</nct_id>
    <nct_alias>NCT00472979</nct_alias>
  </id_info>
  <brief_title>Intravascular Ultrasound for Hepatocellular Carcinoma Staging</brief_title>
  <official_title>Intravascular Ultrasound for the Staging of Hepatocellular Carcinoma: a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a
      triphasic CT scan or a magnetic resonance imaging are required. The characterization of
      hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm.

      Since accuracy in the assessment of the number and the size of HCC nodules, as well as of the
      invasion of blood vessels is crucial to determine outcome after liver transplantation due to
      tumour recurrence, there is a need for techniques with a higher definition potential.

      As a consequence, to improve outcome and to optimize organ allocation, patients on the liver
      transplantation waiting list might benefit from intravascular ultrasound as an additional
      examination to complete the pre-transplant tumour staging process.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2007</start_date>
  <completion_date type="Anticipated">September 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <condition>Hepatocellular Carcinoma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intravascular ultrasound of the liver</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hepatocellular carcinoma nodules

          -  patient on liver transplantation waiting list

          -  written informed consent

        Exclusion Criteria:

          -  thrombosis of hepatic veins or vena cava
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antoine Hadengue, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Antoine Hadengue, Prof.</last_name>
    <phone>+41 22 37 29 340</phone>
    <email>antoine.hadengue@hcuge.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Geneva</name>
      <address>
        <city>Geneva</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea De Gottardi, MD PhD</last_name>
      <phone>+41 22 37 29 256</phone>
      <email>andrea.degottardi@hcuge.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2007</study_first_submitted>
  <study_first_submitted_qc>May 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2007</study_first_posted>
  <last_update_submitted>May 16, 2007</last_update_submitted>
  <last_update_submitted_qc>May 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 17, 2007</last_update_posted>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>liver transplantation</keyword>
  <keyword>staging</keyword>
  <keyword>intravascular ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

